NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye injection trial aims to halt Diabetes-Related vision damage
Disease control CompletedThis study tested whether regular injections of a medication called faricimab into the eye could slow or stop damage to the retina caused by diabetic retinopathy. 179 adults with non-proliferative diabetic retinopathy received either regular injections or were observed, with some…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New eye treatment combo tested against standard therapy
Disease control CompletedThis completed study tested whether adding a second drug (B55R2) to an existing treatment (B55R1) works better than using the single drug alone for diabetic retinopathy. Researchers followed 52 adults with non-proliferative diabetic retinopathy for 24 weeks, measuring changes in …
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC